These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38995526)

  • 41. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
    Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF
    Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginal cytokine profile and microbiota before and after lubricant use compared with condomless vaginal sex: a preliminary observational study.
    Tuddenham S; Stennett CA; Cone RA; Ravel J; Macintyre AN; Ghanem KG; He X; Brotman RM
    BMC Infect Dis; 2021 Sep; 21(1):973. PubMed ID: 34537015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies and methodologies on vaginal drug permeation.
    Machado RM; Palmeira-de-Oliveira A; Gaspar C; Martinez-de-Oliveira J; Palmeira-de-Oliveira R
    Adv Drug Deliv Rev; 2015 Sep; 92():14-26. PubMed ID: 25689736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative assessment of primary skin irritants in vitro in a cytotoxicity model: comparison with in vivo human irritation tests.
    Wilhelm KP; Böttjer B; Siegers CP
    Br J Dermatol; 2001 Nov; 145(5):709-15. PubMed ID: 11736893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dermo-epidermal organotypic cultures for in vitro evaluation of skin irritation and corrosion.
    Gaviria Agudelo C; Becerra NY; Vergara JD; Correa LA; Estrada S; Restrepo LM
    Toxicol In Vitro; 2020 Mar; 63():104657. PubMed ID: 31644923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model.
    Kose O; Erkekoglu P; Sabuncuoglu S; Kocer-Gumusel B
    Regul Toxicol Pharmacol; 2018 Oct; 98():268-273. PubMed ID: 30138660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of the EpiOcular(TM) eye irritation test for hazard identification and labelling of eye irritating chemicals in response to the requirements of the EU cosmetics directive and REACH legislation.
    Kaluzhny Y; Kandárová H; Hayden P; Kubilus J; d'Argembeau-Thornton L; Klausner M
    Altern Lab Anim; 2011 Sep; 39(4):339-64. PubMed ID: 21942547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™.
    Kandarova H; Willoughby JA; De Jong WH; Letasiova S; Milasova T; Bachelor MA; Breyfogle B; Handa Y; De la Fonteyne L; Coleman KP
    Toxicol In Vitro; 2018 Aug; 50():407-417. PubMed ID: 29438733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging Trends and Potential Prospects in Vaginal Drug Delivery.
    Mahant S; Sharma AK; Gandhi H; Wadhwa R; Dua K; Kapoor DN
    Curr Drug Deliv; 2023; 20(6):730-751. PubMed ID: 35422213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ocular irritation reversibility assessment for personal care products using a porcine corneal culture assay.
    Donahue DA; Avalos J; Kaufman LE; Simion FA; Cerven DR
    Toxicol In Vitro; 2011 Apr; 25(3):708-14. PubMed ID: 21172418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
    Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
    Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol.
    Katoh M; Hamajima F; Ogasawara T; Hata K
    J Toxicol Sci; 2009 Jun; 34(3):327-34. PubMed ID: 19483386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of vaginal lubricants on natural fertility.
    Steiner AZ; Long DL; Tanner C; Herring AH
    Obstet Gynecol; 2012 Jul; 120(1):44-51. PubMed ID: 22914390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved procedures for in vitro skin irritation testing of sticky and greasy natural botanicals.
    Molinari J; Eskes C; Andres E; Remoué N; Sá-Rocha VM; Hurtado SP; Barrichello C
    Toxicol In Vitro; 2013 Feb; 27(1):441-50. PubMed ID: 22906570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and human testing strategies for skin irritation.
    Robinson MK; Osborne R; Perkins MA
    Ann N Y Acad Sci; 2000; 919():192-204. PubMed ID: 11083109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaginal tamoxifen for treatment of vulvar and vaginal atrophy: Pharmacokinetics and local tolerance in a rabbit model over 28 days.
    Chollet J; Mermelstein F; Rocamboli SC; Friend DR
    Int J Pharm; 2019 Oct; 570():118691. PubMed ID: 31518632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model.
    Kaluzhny Y; Kandárová H; d'Argembeau-Thornton L; Kearney P; Klausner M
    J Vis Exp; 2015 Aug; (102):e52979. PubMed ID: 26325674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
    McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.